← Back to directory

Mien‐Chie Hung

Researcher Next ID · RN-023724

Researcher · Medicine

The University of Texas MD Anderson Cancer Center

Houston, China

Not currently recruitingFunding unknown
Works count
1,484
Citation count
98,427
H-index
161
i10-index
676

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
HER2/EGFR in Cancer Research
RNA modifications and cancer
Cancer-related Molecular Pathways
Monoclonal and Polyclonal Antibodies Research
Cancer-related gene regulation

Publications

  • PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis

    Nature Cell Biology · 2020 · https://doi.org/10.1038/s41556-020-0575-z

  • Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy

    Cancer Cell · 2019 · 10.1016/j.ccell.2019.06.008

  • Mechanisms Controlling PD-L1 Expression in Cancer

    Molecular Cell · 2019 · 10.1016/j.molcel.2019.09.030

  • Long noncoding RNA MALAT1 suppresses breast cancer metastasis

    Nature Genetics · 2018 · 10.1038/s41588-018-0252-3

  • BAP1 links metabolic regulation of ferroptosis to tumour suppression

    Nature Cell Biology · 2018 · https://doi.org/10.1038/s41556-018-0178-0

  • Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1

    Molecular Cell · 2018 · 10.1016/j.molcel.2018.07.030

  • PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression

    Clinical Cancer Research · 2017 · 10.1158/1078-0432.ccr-16-3215

  • Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity

    Nature Communications · 2016 · https://doi.org/10.1038/ncomms12632

  • Deubiquitination and Stabilization of PD-L1 by CSN5

    Cancer Cell · 2016 · 10.1016/j.ccell.2016.10.010

  • Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer

    Cancer Cell · 2013 · 10.1016/j.ccr.2013.01.022

  • p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs

    Nature Cell Biology · 2011 · 10.1038/ncb2173

  • Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer

    Journal of Clinical Oncology · 2009 · 10.1200/jco.2009.19.6410

  • ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

    Nature Cell Biology · 2008 · 10.1038/ncb1676

  • An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer

    Cancer Research · 2008 · https://doi.org/10.1158/0008-5472.can-07-6854

  • Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer

    Nature Clinical Practice Oncology · 2006 · 10.1038/ncponc0509

  • Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition

    Nature Cell Biology · 2004 · https://doi.org/10.1038/ncb1173

  • PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients

    Cancer Cell · 2004 · 10.1016/j.ccr.2004.06.022

  • IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a

    Cell · 2004 · 10.1016/s0092-8674(04)00302-2

  • Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells

    Nature Cell Biology · 2001 · 10.1038/35060032

  • HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation

    Nature Cell Biology · 2001 · 10.1038/ncb1101-973

  • Nuclear localization of EGF receptor and its potential new role as a transcription factor

    Nature Cell Biology · 2001 · 10.1038/ncb0901-802

  • β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression

    Proceedings of the National Academy of Sciences · 2000 · 10.1073/pnas.060025397

  • Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.

    PubMed · 1997

  • Requirement for neuregulin receptor erbB2 in neural and cardiac development

    Nature · 1995 · 10.1038/378394a0

  • Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185

    Cell · 1986 · 10.1016/0092-8674(86)90779-8

  • The neu oncogene encodes an epidermal growth factor receptor-related protein

    Nature · 1986 · 10.1038/319226a0

Current projects

    No projects listed.